On April 5, China Chamber of Commerce for Import and Export of Medicines and Health Products issued a statement on the so-called "reciprocal tariffs" imposed by the United States.

On April 2, 2025, Eastern Time, the US government announced the imposition of so-called "reciprocal tariffs" on all trading partners, including China. Most medical consumables, dressings, medical equipment and its parts, rehabilitation supplies and other products are affected, especially some products are superimposed on the unreasonable tax increase measures of the US government in the past, and the tariffs have reached extremely high levels.

The unilateral trade measures of the US government ignore the rules of the World Trade Organization, which will not only seriously affect the production and operation of global pharmaceutical industry companies including China, but also seriously affect the research and development, production and stability of the global pharmaceutical industry supply chain, and damage the health and well-being of people in countries around the world, especially seriously affecting the medical security of relevant middle- and low-income groups.

The value of life is supreme. The China Chamber of Commerce for Import and Export of Medicines and Health Products believes that the health rights and interests of the global public should not be infringed by unfair trade measures, and firmly opposes the unilateral trade bullying by the United States. We firmly support the countermeasures taken by the Chinese government, and will work with the pharmaceutical industry of countries around the world to safeguard the legitimate rights and interests of global pharmaceutical companies and jointly promote the healthy development of this important livelihood industry.

https://finance.eastmoney.com/a/202504073365811282.html